FDA announces new limits on high-dose simvastatin (Zocor)
The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in rare cases, kidney damage and failure.
The American Heart Association recommends that all physicians and patients follow the FDAs recommendations regarding high-dose simvastatin.
Simvastatin is prescribed, along with a healthy diet and exercise to lower the low-density lipoprotein (LDL) cholesterol (bad cholesterol) in the blood, and to decrease the risk of heart attack, stroke, and cardiovascular death. It is used in doses ranging from 10 mg to 80 mg. per day.
The changes are based on the FDAs recent review of the SEARCH trial, a seven-year, randomized double-blind clinical trial comparing patients with a previous heart attack taking 80 mg of simvastatin daily vs. 20 mg. daily. The trial found that the incidence of major vascular events was 25.7 percent for those taking 20 mg vs. 24.5 percent taking 80 mg. Approximately 52 patients in the study taking the 80 mg. dose experienced myopathy. About 60 percent of those experiencing myopathy had a genetic difference making it more likely.
A rare but serious form of myopathy, called rhabdomyolysis, can damage the kidneys and lead to potentially fatal kidney failure.
The American Heart Association supports the FDA recommendations for:
· Patients who have taken the 80 mg. dose of simvastatin for a year or more without myopathy to remain on their current dose, unless recommended otherwise by their healthcare provider.
· Patients with any symptoms of muscle pain or weakness, dark or red urine, or unexplained tiredness to contact their healthcare provider immediately.
· Patients taking 80 mg. of simvastatin for less than a year to talk to their provider about changing their dose, and not to discontinue their dose on their own.
· Healthcare providers not to write new prescriptions for 80 mg. simvastatin or increase patients dosage to 80 mg.
· Providers to reduce the dosage or try an alternative drug to lower LDL cholesterol for patients taking 80 mg. simvastatin daily for less than a year.
According to the FDA, in 2010, 2.1 million Americans were taking the 80 mg. dose of simvastatin.
Provided by
American Heart Association
-
Scientists create new cell lines from ocular melanoma patients
Mar 11, 2011 |
not rated yet |
0
-
Fighting drug-resistant 'super-bugs': UCLA expert offers protection tips
May 11, 2011 |
not rated yet |
0
-
New imaging technology predicts fracture risk
Oct 27, 2010 |
not rated yet |
0
-
Cardiac cells might help fix heart attack damage
Jun 08, 2011 |
not rated yet |
0
-
Enzyme enhances, erases long-term memories in rats
Mar 04, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Question of reflection and transmission of TEM wave in normal incidenc
5 hours ago
-
the rudyak-krasnolutski effective potencial
5 hours ago
-
Normal force for a lever model
7 hours ago
-
gravity is std. therefore can we rate a 'mass at height' by watts?
12 hours ago
-
Calculating on-axis elements of a solenoid
May 22, 2013
-
latitude & longitude & air pressure
May 22, 2013
- More from Physics Forums - Classical Physics
More news stories
Dual-source cardiac CT IDs CAD in hard-to-image patients
(HealthDay)—In patients who have previously been considered difficult to image, dual-source cardiac (DSC) computed tomography (CT) can identify clinically significant coronary artery disease, according ...
Cardiology
3 hours ago |
not rated yet |
0
Death rates decline for advanced heart failure patients, but outcomes are still not ideal
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden ...
Cardiology
6 hours ago |
not rated yet |
0
Second-generation TAVI device—Lotus Valve—shows good performance in REPRISE II
22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...
Cardiology
10 hours ago |
not rated yet |
0
Costs to treat stroke in America may double by 2030
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
Cardiology
May 22, 2013 |
not rated yet |
0
New blood-thinner measures may cut medication errors
Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...
Cardiology
May 22, 2013 |
not rated yet |
0
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Multiple research teams unable to confirm high-profile Alzheimer's study
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
Scientists discover molecule triggers sensation of itch
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Type 2 diabetes progresses faster in kids, study finds
(HealthDay)—Type 2 diabetes is more aggressive in children than adults, with signs of serious complications seen just a few years after diagnosis, new research finds.
Motion quotient: IQ predicted by ability to filter motion (w/ video)
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...
Researchers find common childhood asthma unconnected to allergens or inflammation
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...
Jun 09, 2011
Rank: not rated yet